Eric Durot
Reims, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 11, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
Journal: British journal of haematology
Published: May 28, 2026
Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study.
Journal: Haematologica
Published: November 06, 2025
Large B-cell lymphoma: The LYSA pragmatic guidelines.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 21, 2025
POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.
Journal: Blood advances
Published: July 14, 2025
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström Macroglobulinemia.
Journal: Blood advances
Published: July 14, 2025
Last Updated: 09/26/2026